J0593 – Injection, lanadelumab-flyo, 1 mg (code may be used for medicare when drug administered under direct supervision of a physician, not for use when drug is self-administered)
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ0593
- Long description
- Injection, lanadelumab-flyo, 1 mg (code may be used for medicare when drug administered under direct supervision of a physician, not for use when drug is self-administered)
- Short description
- Inj., lanadelumab-flyo, 1 mg
- Pricing indicator
51Drugs- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
O1EOther drugs- Added
- October 1, 2019
- Last change
- January 1, 2024 – No change
Frequently asked questions
What is HCPCS code J0593?
J0593 is a HCPCS Level II code for injection, lanadelumab-flyo, 1 mg (code may be used for medicare when drug administered under direct supervision of a physician, not for use when drug is self-administered).
Does Medicare cover J0593?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J0584 – Injection, burosumab-twza 1 mg
- J0585 – Injection, onabotulinumtoxina, 1 unit
- J0586 – Injection, abobotulinumtoxina, 5 units
- J0587 – Injection, rimabotulinumtoxinb, 100 units
- J0588 – Injection, incobotulinumtoxin a, 1 unit
- J0589 – Injection, daxibotulinumtoxina-lanm, 1 unit
- J0591 – Injection, deoxycholic acid, 1 mg
- J0592 – Injection, buprenorphine hydrochloride, 0.1 mg
- J0594 – Injection, busulfan, 1 mg
- J0595 – Injection, butorphanol tartrate, 1 mg
- J0596 – Injection, c1 esterase inhibitor (recombinant), ruconest, 10 units
- J0597 – Injection, c-1 esterase inhibitor (human), berinert, 10 units
- J0598 – Injection, c-1 esterase inhibitor (human), cinryze, 10 units
- J0599 – Injection, c-1 esterase inhibitor (human), (haegarda), 10 units
- J0600 – Injection, edetate calcium disodium, up to 1000 mg
- J0601 – Sevelamer carbonate (renvela or therapeutically equivalent), oral, 20 mg (for esrd on dialysis)
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.